AS
Anubha Sinha
About Anubha Sinha
Data last updated:
Anubha Sinha has 8 years in corporate governance. Holds Director role. Currently with 2 companies, including Xenrid Pharma Private Limited and Aishani Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Aishani Pharmaceutical Private Limited at ₹14.6 Lakh (FY 2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 06 Dec 2017 | 2017 | ₹14.6 Lakh (FY 2021) | Active | |
| Director | 13 Oct 2025 | 2025 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anubha Sinha
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anubha Sinha
Anubha Sinha has 8 years in corporate governance. Holds Director role. Currently with 2 companies, including Xenrid Pharma Private Limited and Aishani Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Aishani Pharmaceutical Private Limited at ₹14.6 Lakh (FY 2021).
Anubha Sinha is associated with 2 companies as Director, including Aishani Pharmaceutical Private Limited (₹14.6 Lakh), Xenrid Pharma Private Limited.
Anubha Sinha has expertise in General Business.
Anubha Sinha has 8 years in corporate governance.
By reported revenue, the largest current company of Anubha Sinha is Aishani Pharmaceutical Private Limited, with revenue of ₹14.6 Lakh (FY 2021).
Anubha Sinha currently holds positions at 2 companies: Aishani Pharmaceutical Private Limited (₹14.6 Lakh), Xenrid Pharma Private Limited.